High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

W. P. Peters, Maureen Ross, James J. Vredenburgh et al. · Journal of Clinical Oncology · 1993 · 502 citations

Medicine, Oncology, Breast Oncology +10

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.

W. R. Bezwoda, L. Seymour, Roger Dansey · Journal of Clinical Oncology · 1995 · 407 citations

Medicine, Oncology, Pharmacology +14

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

W. P. Peters, E.J. Shpall, R B Jones et al. · Journal of Clinical Oncology · 1988 · 384 citations

Medicine, Oncology, Pharmacology +13

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.

Karen H. Antman, Philip A. Rowlings, William P. Vaughan et al. · Journal of Clinical Oncology · 1997 · 328 citations

Medicine, Hematology, Oncology +14

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

Sjoerd Rodenhuis, Dick J. Richel, Elsken van der Wall et al. · The Lancet · 1998 · 243 citations

Medicine, Oncology, Breast Oncology +16